Also trades as: ACT.DE (XETRA) · $vol 4M
ALZCF OTC
AlzChem Group AG
1W: +0.0%
1M: +0.0%
3M: -0.4%
YTD: +10.8%
1Y: +9.1%
3Y: +619.7%
$184.90
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$137M
+30.3% ▲
5Y CAGR: +23.0%
Capital Expenditures
$98M
-126.8% ▼
5Y CAGR: +27.7%
Free Cash Flow
$39M
-62.7% ▼
5Y CAGR: +14.6%
Dividends Paid
$18M
-48.9% ▼
Buybacks
$5M
-198.8% ▼
Net Change in Cash
$17M
-64.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $37M | $41M | $48M | $75M | $63M |
| Depreciation & Amort. | $24M | $26M | $26M | $26M | $27M |
| Stock-Based Comp. | $159K | $677K | $2M | $0 | $0 |
| Change in Working Capital | -$16M | -$60M | -$7M | -$8M | -$27M |
| Other Non-Cash Items | -$2M | -$11M | $9M | $12M | $74M |
| Operating Cash Flow | $43M | -$4M | $73M | $105M | $137M |
| — Investing Activities — | |||||
| Capital Expenditures | -$29M | -$29M | -$21M | $0 | -$98M |
| Acquisitions (Net) | $56K | $68K | $9K | $0 | $41K |
| Investment Purchases | $0 | $29M | $0 | $0 | $0 |
| Investment Sales | $0 | $489K | $0 | $0 | $846K |
| Other Investing | -$28M | -$29M | $9K | -$31M | $0 |
| Investing Cash Flow | -$28M | -$29M | -$21M | -$31M | -$97M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$13M | $46M | -$36M | -$9M | -$8M |
| Stock Repurchased | -$1M | $0 | $0 | -$2M | -$5M |
| Dividends Paid | -$8M | -$10M | -$11M | -$12M | -$18M |
| Other Financing | -$2M | -$2M | -$2M | -$2M | -$2M |
| Financing Cash Flow | -$24M | $34M | -$49M | -$25M | -$29M |
| Net Change in Cash | -$9M | $958K | $3M | $50M | $17M |
| Cash End of Period | $8M | $9M | $12M | $62M | $72M |
| Free Cash Flow | $14M | -$33M | $52M | $105M | $39M |